Physician profile
Vasanth Stalin
NPI 1265694335
$16,845.41
in general payments reported to CMS, 2019-2025
12 companies · $219 in 2025
The $219 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,610 · 2020: $18.76 · 2021: $4,745 · 2022: $1,402 · 2023: $7,638 · 2024: $213 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,029 · Travel and Lodging: $1,269 · Food and Beverage: $651 · Gift: $121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,028.90 |
| Travel and Lodging | $1,268.82 |
| Food and Beverage | $650.81 |
| Gift | $120.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,830.49 | 2021-2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $4,996.20 | 2021-2022 | |
| Heron Therapeutics, INC. | $1,690.30 | 2019 | |
| W. L. Gore & Associates, INC. | $853.70 | 2019 | |
| Novo Nordisk INC | $626.54 | 2019-2025 | Wegovy |
| Davol INC. | $516.84 | 2022-2025 | Arista |
| Takeda Pharmaceuticals U.S.A., INC. | $178.19 | 2021-2022 | |
| Covidien Lp | $55.27 | 2019 | |
| Lilly USA, LLC | $32.50 | 2025 | Zepbound |
| Integra Lifesciences Corporation | $26.62 | 2023 | Integra, Omnigraft, Integra Dermal Regeneration Template |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Endogastric Solutions, INC | $18.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasanth Stalin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.